AGP Picks
View all

Connecticut Health Digest
Provided by AGP

Connecticut Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Connecticut Health Digest.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 8, 2026

Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
Jun. 8, 2026

Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet

Indeterminate GlobeNewswire
National Action Urged to Address Chronic Pain Crisis Among Women and Women Veterans in Canada
Jun. 8, 2026

National Action Urged to Address Chronic Pain Crisis Among Women and Women Veterans in Canada

Indeterminate GlobeNewswire
Appel À Une Action Nationale Pour Lutter Contre La Crise De La Douleur Chronique Chez Les Femmes Et Les Vétéranes Au Canada
Jun. 8, 2026

Appel À Une Action Nationale Pour Lutter Contre La Crise De La Douleur Chronique Chez Les Femmes Et Les Vétéranes Au Canada

Indeterminate GlobeNewswire
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress
Jun. 8, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress

Indeterminate GlobeNewswire
AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
Jun. 8, 2026

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Indeterminate GlobeNewswire
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China
Jun. 8, 2026

Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China

Indeterminate GlobeNewswire
Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teens
Jun. 8, 2026

Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teens

Indeterminate GlobeNewswire
Rhea's Factory Wins Global Change Award 2026 for AI-Designed Enzymes Enabling Textile-to-Textile Recycling
Jun. 8, 2026

Rhea's Factory Wins Global Change Award 2026 for AI-Designed Enzymes Enabling Textile-to-Textile Recycling

Indeterminate GlobeNewswire
Just Salad Opens in Altamonte Springs, Fla.
Jun. 8, 2026

Just Salad Opens in Altamonte Springs, Fla.

Indeterminate GlobeNewswire
Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders
Jun. 8, 2026

Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders

Indeterminate GlobeNewswire
Longevitix Launches Clinical Intelligence Platform for Preventive and Longevity Medicine
Jun. 8, 2026

Longevitix Launches Clinical Intelligence Platform for Preventive and Longevity Medicine

Indeterminate GlobeNewswire
InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures
Jun. 8, 2026

InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures

Indeterminate GlobeNewswire
Hexiris Ophthalmics Marks Scientific Milestones, Launches Digital Presence, and Announces Hands-On Dry Lab at COS Annual Meeting, Montreal
Jun. 8, 2026

Hexiris Ophthalmics Marks Scientific Milestones, Launches Digital Presence, and Announces Hands-On Dry Lab at COS Annual Meeting, Montreal

Indeterminate GlobeNewswire
Oncotelic Showcases PDAOAI™ Capability in Advancing Drug Development. Featured in Qdrant Vector Space Day 2026 Keynote
Jun. 8, 2026

Oncotelic Showcases PDAOAI™ Capability in Advancing Drug Development. Featured in Qdrant Vector Space Day 2026 Keynote

Indeterminate GlobeNewswire
MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment
Jun. 8, 2026

MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment

Indeterminate GlobeNewswire
Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026
Jun. 8, 2026

Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026

Indeterminate GlobeNewswire
BioCardia Announces $4.4 Million Financing
Jun. 8, 2026

BioCardia Announces $4.4 Million Financing

Indeterminate GlobeNewswire
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
Jun. 8, 2026

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development

Indeterminate GlobeNewswire
Hyperion DeFi Reiterates Guidance on Sunset of USDH and Felix Markets
Jun. 8, 2026

Hyperion DeFi Reiterates Guidance on Sunset of USDH and Felix Markets

Indeterminate GlobeNewswire
Cytokinetics Announces Call for Proposals for Annual Corporate Giving Program
Jun. 8, 2026

Cytokinetics Announces Call for Proposals for Annual Corporate Giving Program

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Connecticut Health Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.